Institutions
Top 10 Educational Resources of 2021
In this blog, we take a look at popular blog posts and webinars in 2021 garnering the most interest from research community members like you.
Unique Ethical Issues in Phase I Oncology Studies
An essential step in research, Phase I oncology studies raise unique ethical challenges for sponsors, investigators, and IRBs.
How Advarra Helps Institutions
Expand your team's bandwidth throughout the research lifecycle with Advarra's integrated solutions. Advarra knows institutions.
Returning to In-person Work: Sponsor Versus Site Viewpoints
An Advarra Trend Report found sites and sponsors alike are facing shifts as they continue to navigate the pandemic.
Creating Opportunities for Inclusion, Diversity, Equity and Access In Clinical Research: A Discussion with Tiffany Danielle Pineda, Brian Sevier, and Wendy Tate
About the Advarra In Conversations With… The future of healthcare innovation hinges on research and clinical trials. Advarra sits down...
Effectively Working with a Research Technology Vendor During Implementation
Maintaining an effective partnership with your technology vendor is key to implementation success.
Advarra Trend Report: Analyzing Sites by Organization Type
Clinical Research Workforce survey finds sites once had similar habits, but everyone is approaching the "next normal" differently.
Clinical Research Nursing Core Curriculum
Candi Barlow of Advarra authored Chapter 8 on Recruitment and Retention in "Clinical Research Nursing Core Curriculum".
Maintaining Data & Reporting Integrity with Mobile Health
Understand how to properly handle and evaluate incoming data gathered using mobile health (mHealth) apps and technologies.
Video: Clinical Conductor CTMS
Clinical Conductor CTMS centralizes management of startup, recruiting, operations, compliance, finances, and reporting
Top Clinical Research Metrics for 5 Critical Questions
Tracking your research program's operational performance has many benefits. View this infographic for metrics to answer key questions.
Op-ed: Missing Elements of the Discussion on Decentralized Trials
Dr. Paul Evans, CEO of Velocity Clinical Research weighs in on what's missing in the discussion of decentralized trials.